Press Release Accord BioPharma Announces Commercial Availability of Denosumab Biosimilars OSVYRTI® (denosumab-desu) and JUBEREQ® (denosumab-desu) Accord BioPharma · Jul 23
Press Release Federal Court Grants SerpApi’s Motion to Dismiss Google’s DMCA Lawsuit SerpApi, LLC · Jul 23
Press Release JumpStart VC Fest Returns to Cleveland September 29-30, Spotlighting Midwest Startup Momentum JumpStart Inc. · Jul 23
Press Release Equable Institute Analysis: U.S. Public Pensions Reach Best Funded Status Since 2009 – But Remain $1.13 Trillion Short Equable Institute · Jul 23
Press Release Esquire Financial Holdings, Inc. Reports Second Quarter 2026 Results Esquire Financial Holdings, Inc. · Jul 23
Press Release TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma Johnson & Johnson · Jul 23
Press Release Norfolk Southern reports second quarter 2026 results Norfolk Southern Corporation · Jul 23
Press Release Serve Robotics to Report Second Quarter 2026 Financial Results, Host Conference Call and Webcast on August 6 Serve Robotics Inc. · Jul 23
Press Release PUBLIC TRUST IN HEALTH INNOVATION IS SHAPED MORE BY MINDSET THAN DEMOGRAPHICS, DNV RESEARCH FINDS DNV · Jul 23
Press Release WillScot to Announce Second Quarter 2026 Results on August 6, 2026 and to Present at an Upcoming Investor Conference in August WillScot · Jul 23
Press Release First Mid Bancshares, Inc. Announces Second Quarter 2026 Results First Mid Bancshares, Inc. · Jul 23
Press Release Aemetis to Review Second Quarter 2026 Financial Results on August 6, 2026 Aemetis, Inc. · Jul 23
Press Release Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH Inhibikase Therapeutics · Jul 23